Panbela: Data on: Inhibition of Polyamine Biosynthesis Preserves β Cell Function in Type 1 Diabetes

 

• A Phase 1 clinical study showed that DFMO treatment may provide metabolic benefits to preserve β cell function and health in T1D.

https://www.globenewswire.com/news-release/2023/11/02/2772286/37414/en/Panbela-Announces-Publication-of-Preclinical-and-Clinical-Data-Titled-Inhibition-of-Polyamine-Biosynthesis-Preserves-%CE%B2-Cell-Function-in-Type-1-Diabetes.html